Materials Development, Inc., Arlington Heights, Illinois 60004, United States.
X-ray Science Division, Advanced Photon Source, Argonne National Laboratory, Lemont, Illinois 60439, United States.
Mol Pharm. 2024 Aug 5;21(8):3967-3978. doi: 10.1021/acs.molpharmaceut.4c00313. Epub 2024 Jul 17.
The metastability of amorphous formulations poses barriers to their safe and widespread commercialization. The propensity of amorphous solid dispersions (ASDs) to crystallize is directly linked to their molecular structure. Amorphous structures are inherently complex and thus difficult to fully characterize by experiments, which makes structural simulations an attractive route for investigating which structural characteristics correlate with ASD stability. In this study, we use empirical potential structure refinement (EPSR) to create molecular models of ketoprofen-poly(vinylpyrrolidone) (KTP/PVP) ASDs with 0-75 wt % drug loading. The EPSR technique uses X-ray total scattering measurements as constraints, yielding models that are consistent with the X-ray data. We perform several simulations to assess the sensitivity of the EPSR approach to input parameters such as intramolecular bond rotations, PVP molecule length, and PVP tacticity. Even at low drug loading (25 wt %), ∼40% of KTP molecules participate in KTP-KTP hydrogen bonding. The extent of KTP-PVP hydrogen bonding does not decrease significantly at higher drug loadings. However, the models' relative uncertainties are too large to conclude whether ASDs' lower stabilities at high drug loadings are due to changes in drug-excipient hydrogen bonding or a decrease in steric hindrance of KTP molecules. This study illustrates how EPSR, combined with total scattering measurements, can be a powerful tool for investigating structural characteristics in amorphous formulations and developing ASDs with improved stability.
无定形制剂的亚稳性对其安全和广泛商业化构成了障碍。无定形固体分散体(ASD)结晶的倾向与其分子结构直接相关。无定形结构本质上是复杂的,因此很难通过实验完全表征,这使得结构模拟成为研究哪些结构特征与 ASD 稳定性相关的有吸引力的途径。在这项研究中,我们使用经验势结构精修(EPSR)技术来创建载药量为 0-75wt%的酮洛芬-聚(乙烯基吡咯烷酮)(KTP/PVP)ASD 的分子模型。EPSR 技术使用 X 射线总散射测量作为约束条件,得到与 X 射线数据一致的模型。我们进行了多次模拟,以评估 EPSR 方法对输入参数(如分子内键旋转、PVP 分子长度和 PVP 立构规整性)的敏感性。即使在低载药量(25wt%)下,也有约 40%的 KTP 分子参与 KTP-KTP 氢键相互作用。在较高的载药量下,KTP-PVP 氢键的程度没有明显降低。然而,模型的相对不确定性太大,无法得出结论,即 ASD 在高载药量下稳定性较低是由于药物-赋形剂氢键的变化还是 KTP 分子的空间位阻减小所致。本研究说明了 EPSR 如何与总散射测量相结合,成为研究无定形制剂结构特征和开发稳定性更好的 ASD 的有力工具。